Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 27, 2011, Pages 11256-11261

  Albayram, Onder ^a   Alferink, Judith ^a   Pitsch, Julika ^a   Piyanova, Anastasia ^a   Neitzert, Kim ^a   Poppensieker, Karola ^a   Mauer, Daniela ^a   Michel, Kerstin ^a   Legler, Anne ^b   Becker, Albert ^a   Monory, Krisztina ^b   Lutz, Beat ^b   Zimmer, Andreas ^a   Bilkei Gorzo, Andras ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

CD40 expression; Glial regulation; Morris water maze; Stereological quantification; Telemetric EEG recording

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CANNABINOID 1 RECEPTOR; GLUTAMIC ACID; INTERLEUKIN 6;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN NERVE CELL; EPILEPSY; HIPPOCAMPUS; LEARNING; MAZE TEST; MEMORY; MOUSE; NERVE CELL DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEURITIS; NONHUMAN; PRIORITY JOURNAL; SEIZURE;

AGING; ANIMALS; BRAIN; CELL COUNT; FEMALE; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION; HIPPOCAMPUS; INTERLEUKIN-6; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROGENESIS; NEUROGLIA; NEURONS; RECEPTOR, CANNABINOID, CB1; SEIZURES;

ANIMALIA; MUS;

EID: 79960572625     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1016442108     Document Type: Article

References (54)

1. Murakami S, Murakami H (2005) The effects of aging and oxidative stress on learning behavior in C. elegans. Neurobiol Aging 26:899-905. (Pubitemid 40249493)
2. Li SC, et al. (2004) Transformations in the couplings among intellectual abilities and constituent cognitive processes across the life span. Psychol Sci 15:155-163.
3. Kirkwood TB, Franceschi C (1992) Is aging as complex as it would appear? New perspectives in aging research. Ann N Y Acad Sci 663:412-417. (Pubitemid 23090560)
4. Lucin KM, Wyss-Coray T (2009) Immune activation in brain aging and neurodegeneration: Too much or too little? Neuron 64:110-122.
5. Perry VH, Nicoll JA, Holmes C (2010) Microglia in neurodegenerative disease. Nat Rev Neurol 6:193-201.
6. von Bernhardi R, Tichauer JE, Eugenín J (2010) Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders. J Neurochem112:1099-1114.
7. Bramanti V, Tomassoni D, Avitabile M, Amenta F, Avola R (2010) Biomarkers of glial cell proliferation and differentiation in culture. Front Biosci (Schol Ed) 2:558-570.
8. Kreutzberg GW (1996) Microglia: A sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
9. Hanisch UK, Kettenmann H (2007) Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10:1387-1394.
10. Ito D, Tanaka K, Suzuki S, Dembo T, Fukuuchi Y (2001) Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke 32:1208-1215. (Pubitemid 32825812)
11. Imai Y, Ibata I, Ito D, Ohsawa K, Kohsaka S (1996) A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun 224:855-862. (Pubitemid 26278674)
12. Carrier EJ, et al. (2004) Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Mol Pharmacol 65:999-1007. (Pubitemid 38420506)
13. Walter L, Dinh T, Stella N (2004) ATP induces a rapid and pronounced increase in 2-arachidonoylglycerol production by astrocytes, a response limited by monoacylglycerol lipase. J Neurosci 24:8068-8074. (Pubitemid 39280826)
14. Muccioli GG, et al. (2007) Identification of a novel endocannabinoid- hydrolyzing enzyme expressed by microglial cells. J Neurosci 27:2883-2889. (Pubitemid 46438968)
15. Stella N (2010) Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia 58:1017-1030.
16. Marsicano G, Lutz B (1999) Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 11:4213-4225. (Pubitemid 30009252)
17. Atwood BK, Mackie K (2010) CB2: A cannabinoid receptor with an identity crisis. Br J Pharmacol 160:467-479.
18. Stella N (2009) Endocannabinoid signaling in microglial cells. Neuropharmacology 56 (Suppl 1):244-253.
19. Oka S, Ishima Y, Waku K, Sugiura T (2006) Endocannabinoids as retrograde messengers in synaptic transmission. Endocannabinoids: The Brain and Body's Marijuana and Beyond, eds Onaivi ES, Sugiura T, Di Marzo V (CRC, Boca Raton, FL), pp 133-149.
20. Katona I, Freund TF (2008) Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med 14:923-930.
21. Marsicano G, et al. (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302:84-88. (Pubitemid 37210691)
22. Klegeris A, McGeer PL (2003) Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAP. J Leukoc Biol 73:369-378. (Pubitemid 36790853)
23. Do Y, McKallip RJ, Nagarkatti M, Nagarkatti PS (2004) Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: Novel role for endogenous and exogenous cannabinoids in immunoregulation. J Immunol 173:2373-2382. (Pubitemid 39063093)
24. Bisogno T, Di Marzo V (2010) Cannabinoid receptors and endocannabinoids: Role in neuroinflammatory and neurodegenerative disorders. CNS Neurol Disord Drug Targets 9:564-573.
25. Centonze D, Finazzi-Agrò A, Bernardi G, Maccarrone M (2007) The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Trends Pharmacol Sci 28:180-187. (Pubitemid 46483718)
26. Bilkei-Gorzo A, et al. (2005) Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors. Proc Natl Acad Sci USA 102:15670-15675. (Pubitemid 41528114)
27. Bilkei-Gorzo A, et al. (2011) Early onset of ageing-like changes is restricted to cognitive abilities and skin structure in Cnr1-/- mice. Neurobiol Aging, in press.
28. Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA 96:5780-5785. (Pubitemid 29234695)
29. Chen K, et al. (2006) CD40/CD40L dyad in the inflammatory and immune responses in the central nervous system. Cell Mol Immunol 3:163-169.
30. Jin K, et al. (2004) Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. Mol Pharmacol 66:204-208. (Pubitemid 38989476)
31. Kenney JW, Gould TJ (2008) Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. Mol Neurobiol 38:101-121.
32. Cohen JD, et al. (1997) Temporal dynamics of brain activation during a working memory task. Nature 386:604-608.
33. Palop JJ, et al. (2007) Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 55:697-711. (Pubitemid 47321079)
34. Sloviter RS, Zappone CA, Harvey BD, Frotscher M (2006) Kainic acid-induced recurrent mossy fiber innervation of dentate gyrus inhibitory interneurons: Possible anatomical substrate of granule cell hyper-inhibition in chronically epileptic rats. J Comp Neurol 494:944-960. (Pubitemid 43063988)
35. Monory K, et al. (2006) The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51:455-466. (Pubitemid 44209321)
36. Lynch MA (2009) The multifaceted profile of activated microglia. Mol Neurobiol 40:139-156.
37. Sparkman NL, Johnson RW (2008) Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress. Neuroimmunomodulation 15:323-330.
38. Ciesielska A, et al. (2007) Influence of age and gender on cytokine expression in a murine model of Parkinson's disease. Neuroimmunomodulation 14:255-265. (Pubitemid 351339992)
39. Lee CK, Weindruch R, Prolla TA (2000) Gene-expression profile of the ageing brain in mice. Nat Genet 25:294-297. (Pubitemid 30437315)
40. Ershler WB (1993) Interleukin-6: A cytokine for gerontologists. J Am Geriatr Soc 41:176-181.
41. Ershler WB, Keller ET (2000) Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 51:245-270. (Pubitemid 30216036)
42. Raivich G, et al. (1999) Neuroglial activation repertoire in the injured brain: Graded response, molecular mechanisms and cues to physiological function. Brain Res Brain Res Rev 30:77-105. (Pubitemid 29331517)
43. Galve-Roperh I, Aguado T, Palazuelos J, Guzmán M (2007) The endocannabinoid system and neurogenesis in health and disease. Neuroscientist 13:109-114. (Pubitemid 46524315)
44. Reibaud M, et al. (1999) Enhancement of memory in cannabinoid CB1 receptor knockout mice. Eur J Pharmacol 379:R1-R2. (Pubitemid 29492956)
45. Maccarrone M, et al. (2002) Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: Correlation with behaviour. Eur J Neurosci 15:1178-1186. (Pubitemid 35463618)
46. Bird CM, Burgess N (2008) The hippocampus and memory: Insights from spatial processing. Nat Rev Neurosci 9:182-194. (Pubitemid 351272664)
47. Matzel LD, Kolata S (2010) Selective attention, working memory, and animal intelligence. Neurosci Biobehav Rev 34:23-30.
48. Howlett AC, et al. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161-202.
49. Azad SC, et al. (2004) Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling. J Neurosci 24:9953-9961. (Pubitemid 39463576)
50. Marsicano G, Moosmann B, Hermann H, Lutz B, Behl C (2002) Neuroprotective properties of cannabinoids against oxidative stress: Role of the cannabinoid receptor CB1. J Neurochem 80:448-456. (Pubitemid 36383028)
51. Cozzi A, et al. (2002) Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: A mechanism for the attenuation of post-ischemic injury and epileptiform activity? Neuropharmacology 43:119-130.
52. Walter L, et al. (2003) Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci 23:1398-1405. (Pubitemid 36258918)
53. Bhat R, et al. (2010) Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci USA 107:2580-2585.
54. Grundy RI, Rabuffetti M, Beltramo M (2001) Cannabinoids and neuroprotection. Mol Neurobiol 24:29-51.